These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Single hepatic venous injection of liver-specific naked plasmid vector expressing human UGT1A1 leads to long-term correction of hyperbilirubinemia and prevention of chronic bilirubin toxicity in Gunn rats. Jia Z; Dankó I Hum Gene Ther; 2005 Aug; 16(8):985-95. PubMed ID: 16076256 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic lentivirus-mediated neonatal in vivo gene therapy in hyperbilirubinemic Gunn rats. Nguyen TH; Bellodi-Privato M; Aubert D; Pichard V; Myara A; Trono D; Ferry N Mol Ther; 2005 Nov; 12(5):852-9. PubMed ID: 16140582 [TBL] [Abstract][Full Text] [Related]
5. Complete correction of hyperbilirubinemia in the Gunn rat model of Crigler-Najjar syndrome type I following transient in vivo adenovirus-mediated expression of human bilirubin UDP-glucuronosyltransferase. Askari FK; Hitomi Y; Mao M; Wilson JM Gene Ther; 1996 May; 3(5):381-8. PubMed ID: 9156798 [TBL] [Abstract][Full Text] [Related]
6. Successful treatment of UGT1A1 deficiency in a rat model of Crigler-Najjar disease by intravenous administration of a liver-specific lentiviral vector. van der Wegen P; Louwen R; Imam AM; Buijs-Offerman RM; Sinaasappel M; Grosveld F; Scholte BJ Mol Ther; 2006 Feb; 13(2):374-81. PubMed ID: 16337205 [TBL] [Abstract][Full Text] [Related]
7. Correction of hyperbilirubinemia in gunn rats using clinically relevant low doses of helper-dependent adenoviral vectors. Dimmock D; Brunetti-Pierri N; Palmer DJ; Beaudet AL; Ng P Hum Gene Ther; 2011 Apr; 22(4):483-8. PubMed ID: 20973621 [TBL] [Abstract][Full Text] [Related]
8. Correction of hyperbilirubinemia in gunn rats by surgical delivery of low doses of helper-dependent adenoviral vectors. Schmitt F; Pastore N; Abarrategui-Pontes C; Flageul M; Myara A; Laplanche S; Labrune P; Podevin G; Nguyen TH; Brunetti-Pierri N Hum Gene Ther Methods; 2014 Jun; 25(3):181-6. PubMed ID: 24593043 [TBL] [Abstract][Full Text] [Related]
9. Adeno-associated virus vector serotypes mediate sustained correction of bilirubin UDP glucuronosyltransferase deficiency in rats. Seppen J; Bakker C; de Jong B; Kunne C; van den Oever K; Vandenberghe K; de Waart R; Twisk J; Bosma P Mol Ther; 2006 Jun; 13(6):1085-92. PubMed ID: 16581301 [TBL] [Abstract][Full Text] [Related]
10. Critical assessment of lifelong phenotype correction in hyperbilirubinemic Gunn rats after retroviral mediated gene transfer. Nguyen TH; Aubert D; Bellodi-Privato M; Flageul M; Pichard V; Jaidane-Abdelghani Z; Myara A; Ferry N Gene Ther; 2007 Sep; 14(17):1270-7. PubMed ID: 17611583 [TBL] [Abstract][Full Text] [Related]
11. Immune response to lentiviral bilirubin UDP-glucuronosyltransferase gene transfer in fetal and neonatal rats. Seppen J; van Til NP; van der Rijt R; Hiralall JK; Kunne C; Elferink RP Gene Ther; 2006 Apr; 13(8):672-7. PubMed ID: 16267566 [TBL] [Abstract][Full Text] [Related]
12. Nonviral gene transfer into liver and muscle for treatment of hyperbilirubinemia in the gunn rat. Dankó I; Jia Z; Zhang G Hum Gene Ther; 2004 Dec; 15(12):1279-86. PubMed ID: 15684703 [TBL] [Abstract][Full Text] [Related]
13. Successful gene therapy of the Gunn rat by in vivo neonatal hepatic gene transfer using murine oncoretroviral vectors. Bellodi-Privato M; Aubert D; Pichard V; Myara A; Trivin F; Ferry N Hepatology; 2005 Aug; 42(2):431-8. PubMed ID: 16025517 [TBL] [Abstract][Full Text] [Related]
14. A step toward liver gene therapy: efficient correction of the genetic defect of hepatocytes isolated from a patient with Crigler-Najjar syndrome type 1 with lentiviral vectors. Birraux J; Menzel O; Wildhaber B; Jond C; Nguyen TH; Chardot C Transplantation; 2009 Apr; 87(7):1006-12. PubMed ID: 19352119 [TBL] [Abstract][Full Text] [Related]
15. In the rat liver, Adenoviral gene transfer efficiency is comparable to AAV. Montenegro-Miranda PS; Pichard V; Aubert D; Ten Bloemendaal L; Duijst S; de Waart DR; Ferry N; Bosma PJ Gene Ther; 2014 Feb; 21(2):168-74. PubMed ID: 24285217 [TBL] [Abstract][Full Text] [Related]
16. Durable correction of inherited metabolic liver disorders requires preventing transgene off-targeting from gene therapy vectors: the value of microRNAs. Gonzalez-Aseguinolaza G; Prieto J Gastroenterology; 2010 Sep; 139(3):726-9. PubMed ID: 20655958 [No Abstract] [Full Text] [Related]
17. Gene therapy with bilirubin-UDP-glucuronosyltransferase in the Gunn rat model of Crigler-Najjar syndrome type 1. Li Q; Murphree SS; Willer SS; Bolli R; French BA Hum Gene Ther; 1998 Mar; 9(4):497-505. PubMed ID: 9525311 [TBL] [Abstract][Full Text] [Related]
18. Ex vivo lentivirus transduction and immediate transplantation of uncultured hepatocytes for treating hyperbilirubinemic Gunn rat. Nguyen TH; Birraux J; Wildhaber B; Myara A; Trivin F; Le Coultre C; Trono D; Chardot C Transplantation; 2006 Sep; 82(6):794-803. PubMed ID: 17006327 [TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil impairs transduction of single-stranded adeno-associated viral vectors. Montenegro-Miranda PS; ten Bloemendaal L; Kunne C; de Waart DR; Bosma PJ Hum Gene Ther; 2011 May; 22(5):605-12. PubMed ID: 21222531 [TBL] [Abstract][Full Text] [Related]
20. Long-term correction of hyperbilirubinemia in the Gunn rat by repeated intravenous delivery of naked plasmid DNA into muscle. Jia Z; Dankó I Mol Ther; 2005 Nov; 12(5):860-6. PubMed ID: 16019265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]